- DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort
[作者:Fontana, L; Bosviel, R; Delort, L; Guy, L; Chalabi, N; Kwiatkowski, F; Satih, S; Rabiau, N; Boiteux, JP; Chamoux, A; Bignon, YJ; Bernard-Gallon, DJ,期刊:Anticancer Research, 页码:1853-1856 , 文章类型: Article,,卷期:2008年28-3B]
- In polygenic diseases, association studies look for genetic variation such as polymorphisms in low penetrance genes, i.e. genes in interaction with environmental factors. DNA repair systems that protect the genome from d...
- Better assessment of nodal metastases by PET/CT fusion compared to side-by-side PET/CT in oesophageal cancer
[作者:Schreurs, LM; Pultrum, BB; Koopmans, KP; Verhoef, CC; Jager, PL; Van Dam, GM; Groen, H; Van der Jagt, EJ; Plukker, JTM,期刊:Anticancer Research, 页码:1867-1873 , 文章类型: Article,,卷期:2008年28-3B]
- Background: Recently, positron emission tomography/computed tomography (PET/CT) has been introduced in the staging of oesophageal cancer. The impact of PET/CT fusion in comparison with side-by-side PET/CT in these tumour...
- Darbepoetin alfa administered every three weeks (Q3W) in anemic cancer patients receiving chemotherapy (CT)
[作者:Martelli, O; Garassino, M; Sacchetta, S; Caristo, R; Zivi, A; Cerbone, L; Mancuso, A,期刊:Anticancer Research, 页码:1767-1771 , 文章类型: Article,,卷期:2008年28-3B]
- Background: Darbepoetin alfa, has a longer half-life than epoetin alfa (rHuEPO) due to its increased sialylated carbohydrate content and can be administered less frequently. Its advantage in terms of response is not enti...
- Polymorphism in MHC Class II Transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients
[作者:Mumtaz, M; Lofgren, S; Hugander, A; Dimberg, J,期刊:Anticancer Research, 页码:1789-1791 , 文章类型: Article,,卷期:2008年28-3B]
- Background: Reduced expression of major histocompatibility complex class II (MHC-II) genes in colorectal cancer (CRC) has been reported. MHC-II transactivator (CIITA), encoded by the MHC2TA gene, is considered to be the ...
- Changes in tumour biological markers during primary systemic chemotherapy (PST)
[作者:Neubauer, H; Gall, C; Vogel, U; Hornung, R; Wallwiener, D; Solomayer, E; Fehm, T,期刊:Anticancer Research, 页码:1797-1804 , 文章类型: Article,,卷期:2008年28-3B]
- Background: The influence of primary systemic therapy (PST) on the expression of relevant therapeutic markers is still under investigation. Patients and Methods: Corresponding "baseline" biopsies and post-chemotherapy su...
- Rectal cancer adjuvant chemotherapy: When is more useful?
[作者:Pasetto, LM; Basso, U; Sinigaglia, G; Pucciarelli, S; Friso, ML; Rugge, M; Toppan, P; Agostini, M; Monfardini, S,期刊:Anticancer Research, 页码:1805-1812 , 文章类型: Article,,卷期:2008年28-3B]
- The aim of the study was to evaluate time-to-progression (TTP) of rectal cancer in a group of patients receiving adjuvant chemotherapy (CHT) after combined neoadjuvant treatment. A secondary end-point was to identify the...
- Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units
[作者:Pasetto, LM; Falci, C; Rizzo, E; De Salvo, GL; Gasparini, G; D'Andrea, M; Bajetta, E; Platania, M; Alabiso, O; Miraglia, S; Oniga, F; Biason, R; Chetri, MC; Fedele, P; Massara, G; Romaniello, I; Giordano, M; Luchena, G; Buzzi, F; Ricotta, R; Siena, S; Monfardini, S,期刊:Anticancer Research, 页码:1813-1820 , 文章类型: Article,,卷期:2008年28-3B]
- Background: Palliative chemotherapy significantly reduces mortality in patients with stage IV colon cancer, but is less prescribed with rising age. In this paper, we highlight the pattern of palliative treatment and poss...
- Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma
[作者:Suzuki, H; Masuda, N; Shimura, T; Araki, K; Kobayashi, T; Tsutsumi, S; Asao, T; Kuwano, H,期刊:Anticancer Research, 页码:1821-1830 , 文章类型: Article,,卷期:2008年28-3B]
- beta-Catenin is a component of the Wingless/Wnt signaling pathway and can activate target genes associated with proliferation and invasion, linking with the APC gene. The purpose of this study was to investigate whether ...
- Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patients
[作者:Mi, ZB; Holmes, FA; Hellerstedt, B; Pippen, J; Collea, R; Backner, A; Bush, JE; Gallion, HH; Wells, A; O'Shaughnessy, JA,期刊:Anticancer Research, 页码:1733-1740 , 文章类型: Article,,卷期:2008年28-3B]
- Background: For chemosensitivity and resistance assays to be clinically useful in predicting patient outcome, they should require small amounts of tissue and be highly reproducible and reliable. Patients and Methods: Exp...
- Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma
[作者:Ohtsuki, K; Koyama, F; Tamura, T; Enomoto, Y; Fujii, H; Mukogawa, T; Nakagawa, T; Uchimoto, K; Nakamura, S; Nonomura, A; Nakajima, Y,期刊:Anticancer Research, 页码:1831-1836 , 文章类型: Article,,卷期:2008年28-3B]
- Background: Tumor 'budding' of colorectal carcinoma along the invasive margin has been associated with increased malignant potential. This study investigated the possible prognostic significance of budding in invasive co...
|